111 related articles for article (PubMed ID: 18386461)
1. Concentrations of follicle stimulating hormone are increased in ovarian tumor fluid: implications for the management of ovarian cancer.
Chudecka-Głaz A; Rzepka-Górska I
Eur J Gynaecol Oncol; 2008; 29(1):37-42. PubMed ID: 18386461
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
3. Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary.
Daraï E; Bringuier AF; Walker-Combrouze F; Feldmann G; Madelenat P; Scoazec JY
Hum Reprod; 1998 Oct; 13(1O):2831-5. PubMed ID: 9804241
[TBL] [Abstract][Full Text] [Related]
4. FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.
Rzepka-Górska I; Chudecka-Głaz A; Kosmowska B
Endocr Relat Cancer; 2004 Jun; 11(2):315-21. PubMed ID: 15163306
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin levels in ovarian cyst fluids: a predictor of malignancy?
Krämer S; Leeker M; Jäger W
Int J Biol Markers; 1998; 13(3):165-8. PubMed ID: 10079392
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
Hazelton D; Nicosia RF; Nicosia SV
Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
8. VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors.
Wang J; Luo F; Lu JJ; Chen PK; Liu P; Zheng W
Int J Cancer; 2002 Jan; 97(2):163-7. PubMed ID: 11774259
[TBL] [Abstract][Full Text] [Related]
9. Follicle stimulating hormone binding inhibiting activity and inhibin properties of human ovarian cystic and porcine follicular fluid.
Rettori V; Van Sickle M; Steinberger A; Asch RH
Acta Eur Fertil; 1984; 15(2):93-7. PubMed ID: 6089484
[TBL] [Abstract][Full Text] [Related]
10. Early inflammatory response in epithelial ovarian tumor cyst fluids.
Kristjánsdóttir B; Partheen K; Fung ET; Yip C; Levan K; Sundfeldt K
Cancer Med; 2014 Oct; 3(5):1302-12. PubMed ID: 24947406
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropins and female sex steroid hormones in cyst fluid and serum from patients with ovarian tumors.
Thomas CM; Boss EA; Boonstra H; van Tienoven D; Sweep CG; Massuger LF
Eur J Gynaecol Oncol; 2008; 29(5):468-72. PubMed ID: 19051814
[TBL] [Abstract][Full Text] [Related]
12. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
[TBL] [Abstract][Full Text] [Related]
13. [The levels of selected hormones in serum and ovarian cyst fluid in girls and young women].
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B; Głaz C
Ginekol Pol; 1999 May; 70(5):236-41. PubMed ID: 10462955
[TBL] [Abstract][Full Text] [Related]
14. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
Candido Dos Reis F; Moreira de Andrade J; Bighetti S
Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in adnexal masses.
Demirkiran F; Kumbak B; Bese T; Arvas M; Benian A; Aydin S; Uzun H; Sanioglu C; Aydinli K; Kösebay D
Int J Gynaecol Obstet; 2003 Oct; 83(1):53-8. PubMed ID: 14511872
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer.
Podzielinski I; Saunders BA; Kimbler KD; Branscum AJ; Fung ET; DePriest PD; van Nagell JR; Ueland FR; Baron AT
Cancer Invest; 2013 May; 31(4):258-72. PubMed ID: 23627408
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of peri- and postmenopausal ovarian cysts.
Reimer T; Gerber B; Müller H; Jeschke U; Krause A; Friese K
Maturitas; 1999 Jan; 31(2):123-32. PubMed ID: 10227005
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin is detectable in the ascitic fluid in patients with ovarian tumors.
Stefanovic V; Pakarinen P; Alfthan H; Stenman UH; Leminen A; Pociuviene J; Riska A; Loukovaara M
Int J Gynecol Cancer; 2012 Nov; 22(9):1470-3. PubMed ID: 23027039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]